News | Latest Breaking News Stories & Headlines

Moderna plans to lay off 10% of workforce to cut costs

Moderna said today it would trim roughly 10% of its global workforce and have fewer than 5,000 employees by the end of the year as the biotech accelerates its cost-cutting efforts amid declining sales of Covid-19 vaccines.

Business • 31 Jul

Shares of vacine maker Moderna slide to four-year low

Moderna pushed its break-even goal by two years as it delayed the timeline for developing several key products and predicted 2025 sales below its forecast for this year, sending its shares down to a four-year low.

Business • 12 Sep 24

Pfizer has cut its full-year forecast for sales of its antiviral Covid treatment Paxlovid by about $7 billion

Pfizer, BioNTech shares fall on sales uncertainty

Shares of Pfizer and German partner BioNTech fell today after the US drugmaker slashed the sales forecast for its Covid vaccine and therapy last week, and some analysts said the reduction was bigger than expectations.

Business • 16 Oct 23

The US vaccine maker is developing a potential next generation booster targeted at both the Omicron variant as well as the original strain

Moderna sees higher Covid vaccine sales later this year

Moderna has forecast higher vaccine sales for the second half of the year than in the first six months, as it expects the virus that causes Covid-19 to follow a more seasonal pattern requiring booster shots in the autumn.

Business • 04 May 22

Moderna said it was in active discussions for additional Covid-19 vaccine contracts this year

Moderna improves forecast for 2022 Covid vaccine sales

Moderna has said it expects to record sales of about $18.5 billion in 2022 from contracts for its Covid-19 vaccine, and about $3.5 billion from potential additional purchases including booster candidates updated for variants.

Business • 10 Jan 22

Moderna has applied to the European Medicines Agency for authorisation for younger people

EMA to decide on Moderna for children within 2 months

The EU's drug watchdog said it expects to decide within two months whether to approve Moderna's Covid-19 vaccine for children aged six to 11.

Coronavirus • 10 Nov 21

The risk, while low, is higher in men under 30 years old and particularly after a second dose of the Moderna vaccine

France advises against Moderna vaccine for under-30s

French health authorities advised against use of the Moderna Covid vaccine for people under 30 late yesterday, after a nationwide study confirmed a slight risk of cardiac inflammation associated with mRNA vaccines.

World • 09 Nov 21

Moderna struggles with vaccine ramp-up, shares drop

Moderna has slashed the 2021 sales forecast for its Covid-19 vaccine by as much as $5 billion, grappling to fill vials and distribute them to meet unprecedented world demand, sending its shares tumbling 16%.

Business • 04 Nov 21

Medical staff prepare syringes of the Moderna vaccine at a vaccination centre in Tokyo

Japan suspends 1m more Moderna shots over contamination

Japan has suspended another million doses of the Moderna Covid-19 vaccine, after foreign substances were found in more batches and two people died following shots from affected lots.

Coronavirus • 30 Aug 21

The companies have said they expect that fully inoculated people will need an extra dose of their vaccines

Pfizer, Moderna could reap billions from booster shots

Drugmakers Pfizer, BioNTech and Moderna are expected to reap billions of dollars from Covid-19 booster shots in a market that could rival the $6 billion in annual sales for flu vaccines for years to come, analysts and healthcare investors say.

Business • 13 Aug 21

The new price for the Pfizer shot was €19.50 against €15.50 previously, according to the report

Pfizer and Moderna raise vaccine prices in EU - report

Pfizer and Moderna have raised the prices of their Covid-19 vaccines in the latest European Union supply contracts, according to a report in The Financial Times today.

Coronavirus • 01 Aug 21

Moderna is now a global name with a multi billion dollar valuation

Focus on Moderna

As conversations continue around the vaccine rollout, one of Moderna's co founders Dr Kenneth Chien talks to The Business.

Business • 28 Jun 21

Philippines President Rodrigo Duterte said he would jail those who refuse to get vaccinated

Duterte threatens to jail those who refuse vaccine

Philippines President Rodrigo Duterte, frustrated by the slow pace of Covid-19 vaccinations in his country, threatened people who refuse to get inoculated with jail or an injection of Ivermectin, an anti-parasite drug widely used to treat animals.

Coronavirus • 22 Jun 21

Vaccinating children is seen as a crucial next step toward herd immunity and ending the pandemic

Pfizer-BioNTech expect vaccine for 12-15 year olds

BioNTech has said that it expected its Covid-19 vaccine, jointly developed with Pfizer, to be available to 12 to 15-year-olds in Europe from June.

Coronavirus • 29 Apr 21

It's not clear what vaccine supplier will be involved

EU looks to secure 1.8bn 2nd-generation vaccine doses

The EU is about to start negotiations with a single pharmaceutical company to secure up to 1.8 billion doses of a "second generation" mRNA vaccine to combat future variants, a European Commission source said.

Coronavirus • 09 Apr 21

The EU commission now has access to a vaccine portfolio of 2.6 billion doses

EU buys up to 300 million more Moderna jabs

The European Commission has said it had struck a deal for an extra 150 million doses of Moderna's Covid-19 vaccine this year, nearly doubling the number of shots secured from the US biotech firm for 2021.

World • 17 Feb 21

About 800 doctors and nurses from across Leinster are being inoculated in the Phoenix Park in Dublin

GPs and nurses get Moderna jab at vaccination centres

Around 1,800 frontline medical workers are receiving a Covid-19 vaccine as part of a targeted vaccination programme this weekend.

Coronavirus • 16 Jan 21

Trials suggest the vaccine is 94% effective

How does the Moderna Covid-19 vaccine work?

Trials of the Moderna coronavirus vaccine suggest it is 94% effective against Covid-19 and no one who was vaccinated with the jab, known as mRNA-1273, developed severe coronavirus.

Coronavirus • 06 Jan 21

Moderna vaccine is the second vaccine for the novel coroanvirus to receive approval from Europe's medicines regulator

Commission clears Moderna Covid vaccine for use in EU

The European Commission has given approval for the use of the Moderna Covid-19 vaccine in the European Union, the final step required to allow its use across the continent.

Coronavirus • 06 Jan 21

Moderna's jab was found to be 94.1% effective in preventing Covid-19 compared to a placebo

No decision on Moderna vaccine - EU regulator

The EU medicines watchdog has said it will continue its discussions about authorising the Moderna coronavirus vaccine on Wednesday.

Coronavirus • 04 Jan 21

The Moderna jab is the second coronavirus vaccine to receive emergency authorisation by the US regulator

US authorises Moderna as second Covid-19 vaccine

The United States has authorised a second Covid-19 vaccine for emergency use against the pandemic, that's killing more than 2,500 people in the US every day.

Coronavirus • 19 Dec 20

The EMA said a cyberattack targeting the agency will not affect approval of vaccines

Pfizer/BioNTech, Moderna vaccine data 'robust' - EMA

Data submitted to the European Medicines Agency by Pfizer/BioNTech and Moderna for their Covid-19 vaccine candidates is "very robust", according to its executive director

Coronavirus • 10 Dec 20

Moderna said study showed no serious safety concerns

Moderna to seek US, EU emergency vaccine authorisation

Moderna has said it will apply for US and European emergency authorisation of its Covid-19 vaccine based on full results from a late-stage study showing its vaccine was 94.1% effective with no serious safety concerns.

Coronavirus • 30 Nov 20

The Moderna deal will be formally approved by the EU executive tomorrow

EU agrees deal for 160 million doses of Moderna vaccine

The European Union has reached a deal with US biotech firm Moderna for the supply of up to 160 million doses of its Covid-19 vaccine candidate, the President of the European Commission has said.

Coronavirus • 24 Nov 20

About a dozen Covid-19 vaccines around the world are currently in the final stages of testing

What progress is being made with Covid-19 vaccines?

Here is everything you need to know about the coronavirus vaccine race.

Coronavirus • 09 Nov 20